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ABSTRACT
Background: Post-operative pain control after Cesarean delivery is a major concern for both patients and physicians. The current
literature provides mixed results on the effectiveness of the local continuous inﬁltration of anesthesia for pain control and reduction of
morphine use.
Methods: This was a randomized, double-blind, placebo controlled trial with a 1:1 group allocation. Fifty women who had a Cesarean
delivery were randomly assigned to receive bupivacaine (Bupivacaine group) or saline (Saline group) delivered via locally placed catheters
at the sub-fascial plane and at the uterine incision. Forty women (20 per group) completed the study. Total post-operative narcotic use
and analog pain scale scores were used to evaluate efﬁcacy of treatment at 6, 12, 24 and 48 hours after surgery.
Results: There was a reduction in pain and narcotic use in the Bupivacaine group at 6, 12, and 48 hours (p < 0.09). Regardless of
group assignment, women who had a prior Cesarean section, versus primagravida women, had a higher total narcotic use (58.06 mg vs.
38.28 mg, respectively; p < 0.03).
Conclusions: Dual catheter placement and infusion of bupivacaine has potential to decrease the use of narcotics and decrease
pain following cesarean section, however, given the small sample size in this study, a signiﬁcant difference between groups could not be
delineated. Further study is indicated to investigate catheter placement and its effects on pain control and narcotic use.
Keywords: Bupivacaine; Cesarean Delivery; Continuous Local Anesthesia; C-Section; Narcotic Use, On-Q™; Pain Control

INTRODUCTION
Cesarean delivery occurs in approximately 32% of deliveries
in the United States [1]. The most conventional methods for
postoperative pain control for these patients include IV narcotic
pain medication (either intermittent or through Patient Controlled
Analgesia (PCA)), intrathecal long-acting narcotics and/or oral
narcotic with or without NSAIDs. These methods provide acceptable
pain relief but are nursing intensive and have the potential for adverse
effects including patient sedation, reduced mentation, respiratory
depression, and decreased bowel function [2]. Moreover, narcotics
have the disadvantage of being excreted into breast milk [3]. Patients
often desire to withhold or minimize narcotic administration due
to these side effects and concerns including safety and addiction
potential. These issues and other extraneous factors result in
postoperative obstetrical pain control that is often suboptimal. High
quality postoperative analgesia is very important for the recovery
of the patient. There are many options available, but tailoring the
method of choice to each patient can be problematic. In addition,
predicting the severity of an individual’s post-operative pain or the
patient’s response to the regimen continues to be a challenge [4]. A
locally delivered, patient controlled method would be advantageous.
The use of the iFlow On-Q™ wound irrigation system for localized
pain control has been shown to be effective for reducing narcotic use
after abdominal surgery [5-8]. Randomized controlled trials have
demonstrated the effectiveness of wound irrigation versus placebo for
reducing narcotic use after Cesarean delivery [9]. There is a growing
literature examining its use after obstetrical surgery where placement
of the catheter has been examined at several positions including at the
fascial or below the sub-fascial planes. However, differences in study
designs and the inconsistency in the catheter placement hampers
interpretation of the findings [7]. To our knowledge, when the wound
irrigation system catheter has been placed at the subcutaneous tissue
above the fascial plane, patients receiving bupivacaine had lower
narcotic use when compared to patients receiving saline, however
the medication group did not report lower pain scores [2]. When
the wound irrigation system catheter was placed at the sub-fascial
plane, it was superior in reducing narcotic use and pain when
compared to postoperative multimodal systemic analgesia that
included acetaminophen, nefopam, celecobix, and patient controlled
intravenous morphine for 24 hours [10]. In contrast, with placement
at the sub-fascial plane, patients receiving levobupivacaine by
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epidural (and saline by catheter) had lower pain scores during the
first four hours after surgery than patients receiving levobupivacaine
by catheter (and saline by epidural), though after four hours, both
groups had similar pain scores and both had similar total narcotic
use [11]. In a randomized study by Rackelboom et al, patients who
received the wound irrigation system catheter placement below the
fascia, had lower narcotics use and lower pain scores compared to
those patients with catheter placement above the fascia [12]. To date,
no study has examined pain control using a local wound irrigation
to both the sub-fascial plane and uterine incision via placement of a
dual catheter system. The purpose of the study was to investigate the
efficacy of continuous wound irrigation system with local anesthetic
to both the sub-fascial plane and the overlying uterine incision in the
peritoneal cavity after Cesarean section for the reduction of postoperative pain and narcotic use.

METHODS
This study was a randomized, double-blind, placebo controlled
trial that was conducted under a research protocol (IRB # 3179)
approved by the Wright State University Institutional Review Board
(Dayton, Ohio). Informed consent was obtained from all patients
prior to their involvement in the trial and the study was compliant
with the Health Insurance Portability and Accountability Act of 1996
(HIPAA).
Patient Selection
Fifty patients were recruited from the house staff service at Miami
Valley Hospital in Dayton, Ohio from May 2013 to February 2015.
Inclusion criteria included individuals undergoing non-emergent
low transverse Cesarean section via pfannensteil incision under
epidural or spinal anesthesia who were between 16 and 45 years old.
Patients were excluded from participation if they were known to have
a coagulopathy, sensitivity to any medications used in the study, or
received Duramorph (long-acting morphine) as part of their predelivery anesthetic regimen. A resident or faculty physician counseled
patients about participation in the study prior to the procedure. Those
interested in participating provided informed consent and signed the
appropriate consent forms for their procedure and for participation
in the study. Minors participating were granted permission from a
guardian. Patients were randomized in a 1:1 group allocation to
receive an anesthetic system filled with normal saline or 0.25% of
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bupivacaine. Randomization using a random numbers generator was
performed by the pharmacy staff at Miami Valley Hospital. Physicians
performing the surgery, researchers, nursing staff, and patients were
all blinded regarding the assignment to local anesthetic or placebo.
Systems were labeled only with participant’s study identification
number. Resident physicians, under supervision from attending
physicians, performed all Cesarean sections and placed the wound
irrigation system catheter in a standardized fashion.
On - Q™ Wound Irrigation System Catheter
A dual catheter iFlow On - Q™ wound irrigation system was placed
with one catheter between the fascia and the rectus muscles and one
catheter overlying the uterine incision in the peritoneal cavity. The
catheters were introduced in the usual fashion through the skin
utilizing separate skin punctures approximately 5 cm superior and/
or lateral to the skin incision. All patients received either bupivacaine
or saline solution via the wound irrigation system. Additionally,
each patient received ketorolac on a scheduled IV basis (30mg
immediately post-operative and every 6 hours for the first 24 postoperative hours). Narcotic pain control was achieved through the
use of a morphine PCA for the first 24 hours and oral hydrocodone/
acetaminophen (Lortab 5/325mg) tablets thereafter with intermittent
IV morphine dosing if needed for breakthrough pain. The amount
of morphine used was documented for the first 24 hours. After 24
hours, total opioid use was calculated using an opioid equivalence of
3mg PO hydrocodone to 1mg IV morphine. Postoperative pain was
assessed in the recovery room and at 6, 12, 24, and 48 hours postoperatively using an 11 - point Likert visual analog pain scale. Nursing
staff who were educated in the study protocol documented patient
reported pain on the visual analog pain scale and documented total
narcotic use in the medical record. All catheters were removed on the
morning of Post Operative Day #3 by the house staff, if the patient
was still hospitalized, or by the patient at home if she had already been
discharged home. Catheters were removed in accordance with the
recommendations of the manufacturer. If patients were discharged
home with catheters in place, a resident or attending physician, prior
to discharge, instructed them how to remove the catheters. Patients
were also provided with the preprinted On - Q™ patient guide to
catheter removal. If a patient had difficulty removing the catheter or
did not feel comfortable removing the catheter themselves at home
they were given an appointment for catheter removal in the office.
Outcomes

Sample Size
Sample size was limited by the number of devices (n = 50)
provided by the Sponsor.

RESULTS
Fifty patients were enrolled in the study ranging in age from 16
- 40 years old and with a gestational age of 37 + 3 to 41 + 0 weeks.
Forty patients were included in the data analysis. Ten patients were
excluded from the analysis, including six who had premature catheter
removal prior to the 48-hour time point related to excessive catheter
leaking at skin insertion point or accidental or intentional patient
self-removal, one due to an allergy requiring changes in narcotic
medication, one for postpartum Ogilvie’s syndrome, and two
who never had the wound irrigation system catheter placed due to
complications at the time of surgery. Ten patients received epidural
anesthesia, 28 patients received spinal anesthesia, and 2 patients
received general anesthesia. All patients were followed for a period of
48 hours. Comparison of the Bupivacaine and Saline groups revealed
no differences with respect to clinical characteristics (see Table 1).
Average total narcotic use at 6, 12, and 48 hours was lower in the
Bupivacaine group compared to the Saline group, although these
differences were not statistically significant (p < 0.15, see Figure 1). At
6, 12, and 48 hours post-operatively, the Bupivacaine group reported
less pain than the Saline group, although not statistically significant
(p < 0.19; See Figure 2). The average narcotic use and pain scores at
24 hours were higher in the Bupivacaine group than in the Saline
group but failed to achieve significance (narcotic use: 21.2mg ± 13.8
Table 1: Clinical Characteristics of Bupivacaine versus Saline Groups.
Bupivacaine Group
(n = 20)

Saline Group
(n = 20)

p value

Age (mean ± sd)

25.1 ± 6.1

27.6 ± 5.9

ns

Gravida

3.8 ± 2.4

3.8 ± 2.6

ns

BMI

37.5 ± 5.9

35.5 ± 6.6

ns

Number Prior C - Sections

1.2 ± 1.3

1.0 ±1.1

ns

African American (% (n))

50% (10)

60% (12)

ns

Caucasian

35% (7)

25% (5)

ns

Smoker

25% (5)

30% (6)

ns

Epidural Anesthesia

25% (5)

25% (5)

ns

Spinal Anesthesia

75% (15)

65% (13)

ns

The primary outcome was total narcotics used for the first 48 hours
post-operatively. An opioid equivalence of 3mg PO hydrocodone
to 1mg IV morphine was used to convert PO hydrocodone before
calculation of the total narcotics used. Secondary measures included
subjective assessment of post-operative pain at 6, 12, 24, and 48 hours.
Baseline characteristics included age, race, gravidity, parity, and Body
Mass Index (BMI) were recorded.
Statistical Analysis
Statistical analyses were performed using the Statistical Package
for the Social Sciences (version 23.0) [13]. Student’s t-test and
Chi Square were used to compare group characteristics. Repeated
measures ANOVA was used to assess change over time for primary
outcomes, total narcotics use, and secondary outcomes, pain scores,
and to compare the treatment assignment groups. Significance was
defined as p < 0.05.
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Figure 1: Average Narcotic Use at 6, 12, 24, and 48 Hours Post C-Section for
Bupivacaine Versus Saline Groups.
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vs. 15.2mg ± 13.3, p < 0.15 and pain scores: 4.3 ± 2.5 vs. 3.5 ± 2.4, p <
0.20). Additional analyses of women with prior C-section compared
to those who were primagravida, revealed that in both Bupivacaine
and Saline groups, women with a prior C-section had higher total
narcotic use (38.3mg ± 20.8 vs. 58.1mg ± 27.5; p < 0.02) compared
to primagravida women (Figure 3). The two groups did not differ
with respect to total narcotic use when race, age, smoking status, and
BMI were controlled. Clinical characteristic for these two groups
are presented in Table 2. With respect to anesthesia type, there were
no differences in total narcotic use or average pain scores. The type
of anesthesia dummy variables were entered into stepwise multiple
regressions predicting total narcotics use and average pain scores,
however, these variables did not enter the prediction equation. Only a
history of previous Cesarean delivery predicted higher total narcotics
use and higher average pain scores.

Table 2: Clinical Characteristics of Primagravida versus Prior Cesarean Section.

DISCUSSION

However, there was a peak of increased narcotic use and pain scores
at the 24 hour time point. Regardless of study group assignment,
patients with prior Cesarean sections had higher total narcotic use
than women for whom this was their primary Cesarean section. The
findings of our study are consistent with the literature demonstrating
no differences in total narcotics use and no difference in pain scores
between patients receiving continuous wound irrigation and patients
receiving intrathecal narcotics [14,15]. While our study is suggestive
of lower narcotics use in the Bupivacaine group, the difference in
pain scores was minimal. This is important because if patients are
experiencing similar pain control and lower narcotics use, then the
benefits of using the continuous wound irrigation method for postoperative pain control will be evident through a decrease in narcotic
side effects, including nausea and vomiting, but also by minimizing
patient concerns regarding narcotic transmission in breastmilk and
addiction potential. The sharp increase in narcotic use at the 24 hr
time point and the accompanying spike in pain was an interesting
finding, which may be accounted for by the earlier post-operative
pain control. Some studies have noted that increased pain occurs
around the time when IV medications are transitioned to oral therapy
[16]. It is possible that earlier mobility at the 24-hour time point
caused an increase in pain sensation, however, mobility parameters
were not documented or included in data collection. The impact
of prior Cesarean section on total narcotic use regardless of study
group assignment, may be attributed to increased pain related to
previous scar tissue and increased manipulation during surgery or
anticipated pain based on their previous experience during their prior
Cesarean section leading to a tendency to over-medicate to avoid
pain. The strengths of our study include that it was a randomized
placebo controlled trial and that its approach included placement of
the dual catheter at the uterine incision and between the fascia and
rectus muscle. The study was designed to be executed in real time
within the standards of post Cesarean wound management. The study
was conducted on a resident service where all patients underwent
standardized surgical procedures and postoperative care. Nursing
staff underwent study specific training to ensure that the required
study information was recorded in the medical record. Placement of
the wound irrigation system was informed by the current literature
showing that placement below the fascia was more effective than
placement above the fascia [12]. However, we acknowledge that there
are study limitations including that not all cases were performed by
the same surgeon and not all of the surgeons had extensive experience
prior to the study for the placement or use of pain catheters at the
time of Cesarean section. This likely contributed to some variance
due to the learning curve associated with catheter placement. We

Our study demonstrated that women who received the On-Q™
wound irrigation system at the sub-fascial and uterine incision planes
demonstrated lower, but not statistically significant, narcotics use and
reduced pain across three of the four time points assessed (6 hr, 12
hr, and 48 hr) leading to lower total narcotic use during the study.

Figure 2: Average Pain Score at 6, 12, 24, and 48 hours Post C-Section for
Bupivacaine Versus Saline Groups.

Figure 3: Average Narcotic Use for women with and without Prior C-Section
for Bupivacaine Saline Groups and combined Groups.
Women with Prior C-Section had higher narcotics use than Primagravida
women (p<0.02 for the Combined Group comparison).
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Primagravida
1+ Prior C (n = 16)
Section (n = 24)

p value

Age (mean ± sd)

24.1 ± 6.6

27.8 ± 5.3

< 0.07

Gravida

2.6 ± 2.5

4.6 ± 2.1

< 0.01

BMI

35.1 ± 5.4

37.4 ± 6.7

ns

Number Prior C - Sections

0.0 ± 0.0

1.8 ± 1.0

n/a

African American (% (n))

50% (8)

58% (14)

ns

Caucasian

37% (6)

25% (6)

ns

Smoker

25% (4)

29% (7)

ns

Epidural Anesthesia

63% (10)

0% (0)

< 0.002

Spinal Anesthesia

37% (6)

92% (22)

< 0.002
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experienced a large number of cases that were excluded from analysis
which impacted power to detect differences. Our post hoc power
analysis (power = 80%, p < 0.05) indicated that we would need 114
patients per group to detect a difference in narcotics use (based on the
group difference at the 48 hour time point) and 99 patients per group
to detect a difference in pain score (based on the group difference at the
48 hour time point) for the small effect sizes we had. Another possible
limitation in this study was that we allowed different anesthesia
options including epidural, spinal, and general were used and not
controlled. The study was executed in the standard labor and delivery
setting in which anesthesia was determined according to patient desire
and physician decision regarding what was in the best interest of the
mother and infant. Further research is necessary with larger numbers
of patients to allow inferences of no difference in pain scores using the
dual catheter placement approach. Future studies will need to include
specific assessment of side effects as this is an important area of patient
concern with narcotics use. While patients may have experienced side
effects, they may not have mentioned them to the nursing staff. If
patients reported experiencing side effects, it is not known whether
nurses would have recorded these in their notes unless the side effects
were particularly bothersome and/or required intervention. As the
culture of medicine changes over the next few years, it is important to
improve patient satisfaction with their birthing experience for many
reasons, including provider reimbursement. The nationwide rate of
Cesarean section remains steady and pain control after surgery can
be a major factor in patient satisfaction. Local infusion of anesthetic
may allow patients to bond better with their babies, mobilize earlier,
and possibly shorten length of stay when compared to traditional
pain control methods. Our results show promise for the dual catheter
placement for the management of postoperative pain and use of postoperative narcotics. However, our study had insufficient power, and
we were unable to demonstrate a significant difference between the
Bupivacaine group and the Saline group. Further clinical trials with
larger sample sizes are needed to address those patients at high risk
of postoperative pain issues including individuals with substance
abuse or undergoing repeat, classical or emergent Cesarean sections
under general anesthetic. Furthermore, the optimal site for the On-Q
wound irrigation system at either or both the sub-fascial and uterine
incision warrants further investigation.
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